SCHEMBL7428178

SCHEMBL7428178

C=C1CNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL15017518 0.95
SCHEMBL7524856 0.79
SCHEMBL15233248 0.79
SCHEMBL8413384 0.76
Hydrochloric Acid SCHEMBL10880510 0.76
SCHEMBL7619160 0.71 CXCR4 (0.47)
SCHEMBL300703 0.65
SCHEMBL1394522 0.63
SCHEMBL20281353 0.61
SCHEMBL16059722 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4260606-A ANTIDEPRESSANTS A. H. ROBINS COMPANY, INC. (US) 1981-04-07 US claimed
US-20250136598-A1 SUBSTITUTED PYRAZOLO-PYRIDINE AMIDES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2025-05-01 US disclosed
WO-2025061102-A1 CYANO-CONTAINING HETEROCYCLIC COMPOUND AND USE THEREOF 西藏海思科制药有限公司 2025-03-27 WO disclosed
US-12172997-B2 Substituted pyrazolo-pyridine amides and their use as GluN2B receptor modulators JANSSEN PHARMACEUTICA NV (BE) 2024-12-24 US disclosed
WO-2024153208-A9 MACROCYCLIC COMPOUNDS, PREPARATION METHOD THEREFOR, AND USE THEREOF 劲方医药科技(上海)有限公司 2024-08-22 WO disclosed
WO-2024153208-A1 MACROCYCLIC COMPOUNDS, PREPARATION METHOD THEREFOR, AND USE THEREOF 劲方医药科技(上海)有限公司 2024-07-25 WO disclosed
CN-118373768-A Preparation method of 3-methylene (benzyl) piperidine 泰州学院 2024-07-23 CN disclosed
WO-2024101402-A1 PHARMACEUTICAL COMPOSITION CONTAINING CYCLIC COMPOUND HAVING SELECTIVE KRAS INHIBITORY EFFECT AGAINST HRAS AND NRAS 中外製薬株式会社 2024-05-16 WO disclosed
US-20240158446-A1 CYCLIC COMPOUND HAVING SELECTIVE INHIBITORY ACTION ON KRAS OVER HRAS AND NRAS CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2024-05-16 US disclosed
WO-2024101386-A1 CYCLIC COMPOUND HAVING SELECTIVE KRAS INHIBITORY EFFECT ON HRAS AND NRAS 中外製薬株式会社 2024-05-16 WO disclosed
WO-2014054053-A1 SPIROCYCLIC COMPOUNDS, COMPOSITIONS AND MEDICINAL APPLICATIONS THEREOF ADVINUS THERAPEUTICS LIMITED (IN) 2014-04-10 WO disclosed
WO-2007044515-A1 AZETIDINES AS MEK INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISEASES EXELIXIS, INC. (US) 2007-04-19 WO disclosed
US-6482827-B1 Matrix metalloproteinase inhibitors PHARMACIA & UPJOHN S.P.A. (IT) 2002-11-19 US disclosed
EP-0925289-A1 MATRIX METALLOPROTEINASE INHIBITORS PHARMACIA &amp; UPJOHN S.p.A. (IT) 1999-06-30 EP disclosed
WO-1999002510-A1 MATRIX METALLOPROTEINASE INHIBITORS PHARMACIA & UPJOHN S.P.A. (IT) 1999-01-21 WO disclosed
US-4260606-A ANTIDEPRESSANTS A. H. ROBINS COMPANY, INC. (US) 1981-04-07 US disclosed
US-4260606-A ANTIDEPRESSANTS A. H. ROBINS COMPANY, INC. (US) 1981-04-07 US disclosed
US-4260606-A ANTIDEPRESSANTS A. H. ROBINS COMPANY, INC. (US) 1981-04-07 US disclosed
US-4242261-A REACTING AN A,A-DIPHENYL-A-N-HETEROCYCLIC ACETAMIDE WITH BROMINE AND AN ALKALI METAL ALKOXIDE AND HEATING A. H. ROBINS COMPANY, INC. (US) 1980-12-30 US disclosed
US-4242261-A REACTING AN A,A-DIPHENYL-A-N-HETEROCYCLIC ACETAMIDE WITH BROMINE AND AN ALKALI METAL ALKOXIDE AND HEATING A. H. ROBINS COMPANY, INC. (US) 1980-12-30 US disclosed